key: cord-0774627-28mcutyr authors: Avdeev, Sergey N.; Yaroshetskiy, Andrey I.; Nuralieva, Galia S. title: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19–associated Acute Hypoxemic Respiratory Failure? date: 2021-03-30 journal: Annals of the American Thoracic Society DOI: 10.1513/annalsats.202101-047le sha: 5168b4cc4889e235c50f70bd7f911b9504a29f74 doc_id: 774627 cord_uid: 28mcutyr nan (50%; 240/484). Of those admitted to the surgical service, 95% (61/64) were managed by thoracic surgery versus general surgery (5%; 3/64), and 83% (53/64) received surgical management, compared with 17% (11/64) who received IPET management. The rate of CPSIs that were in the empyema phase was higher in patients admitted to the surgical service (61%; 39/64) compared with those admitted to the medicine service (41%; 197/484) (P = 0.002). Of the 255 patients who received initial IPET management, 67% (171) had a surgical consultation. Of the 205 patients who received only IPET management, 60% (123) had a surgical consultation. Although surgery is currently recommended for CPSI management by national societies as of 2017 guidelines, we identified its use as an initial strategy to be decreasing in the community setting but still prevalent (2) . This is likely due to more institutions adopting IPET. We identified that although IPET adoption has increased, the use of alternative IPET dosing has also increased and was associated with a higher frequency of crossover into the surgical intervention group. However, this study is retrospective and not powered to show a statistical difference in outcomes, thereby limiting our ability to identify why these clinical decisions were made. A notable finding is that CPSI treatment type does not appear to be influenced by age or RAPID (renal, age, purulence, infection source, and dietary factors) score, as previous studies have suggested (4) . Another is that more patients underwent surgery when the admitting service was surgical. This could reflect the higher rate of CPSIs in the empyema phase being admitted to the surgical service but could also reflect poor surgical candidates more frequently admitted to the medicine service, as well as variability in practice patterns and specialty bias given surgical societies recommending surgery as the primary management strategy (2, 5, 6) . With trends in the management of CPSIs shifting, these data demonstrate a need for randomized trials (NCT04095676, NCT03584113, and NCT03873766) to better develop systematic CPSI treatment plans. Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure? To the Editor: We read with great interest the article by Bellani and colleagues, "Noninvasive Ventilatory Support of Patients with COVID-19 outside the Intensive Care Units (WARd-COVID)," published in AnnalsATS also showed that lower arterial oxygen pressure (Pa O 2 )/fraction of inspired oxygen (FI O 2 ) ratio, higher CRP (C-reactive protein) concentrations, and lower platelet counts were independently associated with an increased risk of NIV failure. However, we believe that using the Pa O 2 /FI O 2 ratio is a rather questionable means of predicting NIV failure. First, Pa O 2 /FI O 2 values are inherently inaccurate because the FI O 2 in a nonintubated patient is quite difficult to determine (2) . And this is especially true in the context of non-ICU departments when using free-flow systems under the condition of a gas leak around the mask or helmet. Second, the Pa O 2 /FI O 2 threshold of 150 mm Hg is also rather controversial. In a study by Franco and colleagues (3) (24% and 26%, respectively) . Third, in two other studies (4, 5) conducted outside the ICU, the mortality rates of patients with COVID-19 with even lower baseline Pa O 2 /FI O 2 values during NIV were better than that in the study by Bellani and colleagues: the rate was 17% in a study by Brusasco and colleagues (initial median Pa O 2 /FI O 2 of 119 mm Hg) (4), and the rate was 21% in a study by Nightingale and colleagues (initial median Pa O 2 /FI O 2 of 122 mm Hg) (5). In our recent study, in patients with COVID-19 receiving NIV outside the ICU, the baseline Pa O 2 /FI O 2 index also did not differ between the success and failure groups, but we found that patients who experienced NIV failure had higher minute ventilation on the first day of NIV (due to a slightly higher tidal volume and a higher respiratory rate) (6) , which, of course, may increase the risk of self-inflicted lung injury. These findings are in line with Bellani and colleagues' data, which also showed that the patients experiencing NIV failure had lower arterial carbon dioxide pressure levels. However, we must admit that today in non-ICU settings, it is rather difficult to identify robust markers of possible self-inflicted lung injury. Bellani and colleagues also identified elevated levels of CRP as an independent predictor of NIV failure. Interestingly, in our study, an elevated D-dimer level was an indicator of the increased possibility of NIV failure (6) . Both high CRP levels and high D-dimer levels are associated with the progression of COVID-19 and a higher mortality rate. So, progressive underlying processes in COVID-19 might need prolonged respiratory support and can be associated with NIV failure. In conclusion, because the appropriate patient selection is the key to the successful application of NIV, further research is needed to identify reliable predictors of NIV failure in COVID-19-associated AHRF. Author disclosures are available with the text of this letter at www. atsjournals.org. *Corresponding author (e-mail: jed.gorden@swedish.org) Intrapleural use of tissue plasminogen activator and DNase in pleural infection The American Association for Thoracic Surgery consensus guidelines for the management of empyema BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010 Management of pleural space infections: a population-based analysis A randomized trial of empyema therapy Outcomes of operative and nonoperative treatment of thoracic empyema: a populationbased study COVID-19 Lombardy ICU Network. Noninvasive ventilatory support of patients with COVID-19 utside the intensive care units Why COVID-19 silent hypoxemia is baffling to physicians Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia Is continuous positive airway pressure (CPAP) a new standard of care for type 1 respiratory failure in COVID-19 patients? A retrospective observational study of a dedicated COVID-19 CPAP service Galliera CPAP-COVID-19 Study Group. Continuous positive airway pressure in COVID-19 patients with moderate-to-severe respiratory failure Noninvasive ventilation for acute hypoxemic respiratory failure in patients with COVID-19 COVID-19 Lombardy ICU Network. Noninvasive ventilatory support of patients with COVID-19 utside the intensive care units Reply: Can We Reliably Predict the Failure of Noninvasive Ventilation in COVID-19-associated Acute Hypoxemic Respiratory Failure? We thank Dr. Avdeev and colleagues for their interest in our article (1) and for their comments, which allow us to clarify some points. Their main concern has to do with the prognostic value of the arterial oxygen tension (Pa O 2 )/fraction of inspired oxygen (FI O 2 ) ratio. First, we would like to emphasize the reliability of the FI O 2 even in noninvasive condition; despite the (most likely) presence of leaks, positive pressure will cause a unidirectional gas flow from the inner of the interface (face mask or helmet) toward the ambient pressure. Hence, there is no risk of room air contamination of the fresh gas flow mixture (2). This might not be the case in patients treated with high-flow nasal cannulas, who indeed may inhale room air (especially if breathing with an open mouth), but these patients were not included in our analysis.Regarding the threshold value of the Pa O 2 /FI O 2 ratio, we agree that this is somewhat arbitrary and that the chance of noninvasive ventilation (NIV) failure increases continuously with decreasing Pa